Crime & Legal-Related
(I80)
990 on File
FIRST LEGAL CLINIC
Financial strength (30%)
87/100
Reliability (20%)
40/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$487K
Total Revenue
$411K
Total Expenses
$250K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
78.3%
Fundraising Efficiency
N/A
Operating Reserve
7.32x
Liability-to-Asset
25.6%
Revenue Diversification
90.6%
Compared with Peers
FY 2023
Compared with 2,429 similar organizations
(United States, Crime & Legal-Related, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
78.3% | 83.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
21.7% | 12.3% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.3 mo | 8.5 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
25.6% | 3.2% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
90.6% | 97.1% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-5.4% | 8.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-11.0% | 10.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
15.6% | 3.5% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $487K | $411K | $250K | 78.3% | 0 |
| 2022 | $514K | $461K | $175K | 75.1% | 0 |
| 2021 | $292K | $148K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.